期刊文献+

GAS5和miR-21在前列腺癌中表达的关系及临床意义 被引量:1

Relationship and clinical significance of GAS5 and miR-21 expression in prostate cancer
下载PDF
导出
摘要 目的:分析GAS5和miR-21在前列腺癌中的表达关系,并探讨其临床意义.方法:收集2011年1月至2013年6月在本院行手术切除治疗的80例前列腺癌患者的肿瘤组织和癌旁非肿瘤组织,采用qRT-PCR检测组织中GAS5和miR-21相对表达量,分析肿瘤组织中GAS5和miR-21表达的关系及两者与临床病理特征的关系,采用K-M生存函数分析肿瘤组织中GAS5和miR-21表达与患者预后的关系.结果:肿瘤组织中GAS5相对表达量低于癌旁非肿瘤组织(P<0.05),miR-21相对表达量高于癌旁非肿瘤组织(P<0.05);肿瘤组织中GAS5和miR-21表达水平呈负相关(r=-0.702,P<0.001);肿瘤组织中GAS5和miR-21表达水平与患者TNM分期、Gleason评分和淋巴结未转移有关,与血清PSA水平及前腺体体积无关;80例患者5年总生存率86.25%(69/80),GAS5高表达组无瘤生存期和总生存率均高于GAS5低表达组(P<0.05),miR-21高表达组无瘤生存期和总生存率均低于miR-21低表达组(P<0.05);TNM分期、Gleason评分、淋巴结转移、血清PSA水平及GAS5表达水平、miR-21表达水平是影响前列腺癌患者预后的独立危险因素.结论:前列腺癌中GAS5表达降低,miR-21表达升高,与患者不良预后有关,提示GAS5和miR-21可作为前列腺癌的预后标志物.同时GAS5和miR-21呈负相关,提示两者可能在调控前列腺癌进展及不良预后中存在相互作用. Objective:To analyze the expressions of GAS5 and miR-21 in prostate cancer and explore their clinical significances. Methods:Tumor tissues and adjacent non-tumor tissues were collected from 80 patients with prostate cancer underwent surgical resection in our hospital from January 2011 to June 2013. The relative expressions of GAS5 and miR-21 in tissues were detected by qRT-PCR, analyzed the relationship between the expressions of GAS5 and miR-21 in tumor tissues and the clinicopathological characteristics of patients. K-M survival function was used to analyze the relationships between the expressions of GAS5 and miR-21 with the prognosis of patients. Results:The relative expression of GAS5 in cancer tissues was lower than that in noncancer tissues adjacent to cancer (P<0.05), and the relative expression of miR-21 was higher than that in noncancer tissue adjacent to cancer (P<0.05);there was a negative correlation between the expressions of GAS5 and miR-21 (r=?0.702, P<0.001);the expression levels of GAS5 and miR-21 in tumors were correlated with TNM stage, Gleason score, and lymph node metastasis, but not with serum PSA level and anterior gland volume;the 5-year overall survival rate of 80 patients was 86.25%(69/80), the tumor-free survival and overall survival rate of patients with GAS5 high expression were higher than those with GAS5 low expression (P<0.05), the tumorfree survival and overall survival rate of patients with miR-21 high expression were higher than those with miR- 21 low expression (P<0.05);TNM staging, Gleason score, lymph node metastasis, serum PSA level, and GAS5 expression level, and miR-21 expression level were independent risk factors affecting the prognosis of prostate cancer patients. Conclusion:The expression of GAS5 is decreased and the expression of miR-21 is increased in prostate cancer, which is related to the poor prognosis of the patients, these results suggest that GAS5 and miR-21 can be used as prognostic markers of prostate cancer. At the same time, GAS5 is negatively correlated with miR- 21, these results suggest that there may be an interaction between them in regulating the progression and adverse prognosis of prostate cancer.
作者 李波 王容子 王超 廖泽明 LI Bo;WANG Rongzi;WANG Chao;LIAO Zeming(Department of Urology, Jingmen First People’s Hospital, Jingmen Hubei 448000, China)
出处 《临床与病理杂志》 2019年第7期1421-1427,共7页 Journal of Clinical and Pathological Research
关键词 前列腺癌 GAS5 MIR-21 病理特征 预后 prostate cancer GAS5 miR-21 pathological characteristics prognosis
  • 相关文献

参考文献10

二级参考文献132

  • 1欧洲泌尿学会更新前列腺癌诊疗指南[J].临床泌尿外科杂志,2006,21(5):399-400. 被引量:11
  • 2Lamas M J, Duran G, Gallardo E. Anti-EGFR therapy in first-line colorectal cancer[ J]. Expert Rev Anticancer T- her, 2011, 11 (10) : 1499-1503.
  • 3Adelstein BA, Dobbins TA, Harris CA, et al. A system- atic review and meta-analysis of KRAS status as the deter- minant of response to anti-EGFR antibodies and the impact of partner chemotherapy in metastatic colorectal cancer [J]. Eur J Cancer, 2011,47(9) :1343-1354.
  • 4Garcia-Stenz JA, Sastre J, Dfaz-Rubio Garcia E. Biomar- kers and anti-EGFR therapies for KRAS wild-type meta- static colorectal cancer[ J]. Clin Transl Oncol, 2009, 11 ( 11 ) :737-747.
  • 5Fujita S, Ito T, Mizutani T, et al. miR-21 gene expres-sion triggered by AP-1 is sustained through a double-nega- tive feedback mechanism[ J ]. J Mol Biol, 2008, 378 (3) : 492-504.
  • 6Schetter A J, Leung SY, Sohn J J, et al. MicroRNA ex- pression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma[J]. JAMA, 2008, 299 (4) :425-436.
  • 7Park JK, Lee EJ, Esan C, et al. Antisense inhibition of micmRNA-21 or -221 arrests cell cycle, induces apopto- sis, and sensitizes the effects of gemcitabine in pancreatic adenocarcinoma [ J ]. Pancreas, 2009, 38 ( 7 ) : e190- e199.
  • 8Meng F, Henson R, Lang M, et al. Involvement of human micro-RNA in growth and response to chemotherapy in hu- man cholangiocarcinoma cell lines [ J ]. Gastroenterology, 2006, 130(7) :2113-2129.
  • 9Meng F, Henson R, Wehbe-Janek H, et al. MicroRNA- 21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer [ J ]. Gastroenterology, 2007, 133 (2):647-658.
  • 10Shiozawa Y, Nie B, Pienta KJ, et al. Cancer stem cells and their role in metastasis[J]. Pharmacol Ther, 2013, 138(2): 285-293.

共引文献109

同被引文献8

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部